REG - BioPharma Credit PLC - Notice of Full Year Results

Biopharma CreditAnnouncement

20/02/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250220:nRST7642Xa&default-theme=true

RNS Number : 7642X  BioPharma Credit PLC  20 February 2025

BIOPHARMA CREDIT PLC

(the "Company")

NOTICE OF FULL YEAR RESULTS

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor,
will announce its Full Year Results for the period ending 31 December 2024 on
Tuesday, 25 March 2025.

A sell side presentation will be delivered at 15.00 GMT through a webcast
facility. To register to attend or request details, RSVP
to biopharmacredit@buchanan.uk.com.

-Ends-

Enquiries

Burson Buchanan

Mark Court / Jamie Hooper / Henry Wilson / Samuel Adams

+44 (0) 20 7466 5000

biopharmacredit@buchanan.uk.com (mailto:biopharmacredit@buchanan.uk.com)

Notes to Editors

BioPharma Credit PLC is London's only specialist debt investor to the life
sciences industry and joined the LSE in March 2017. The Company seeks to
provide long-term shareholder returns, principally in the form of sustainable
income distributions from exposure to the life sciences industry. The Company
seeks to achieve this objective primarily through investments in debt assets
secured by royalties or other cash flows derived from the sales of approved
life sciences products.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORFZGMZNLZGKZM